We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002429:SZSEShenzhen MTC Co., Ltd. Analysis

Data as of 2026-06-19 - not real-time

CN¥11.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades at CNY 11.88, comfortably above its 20‑day (11.71) and 50‑day (11.68) SMAs and well above the 200‑day SMA (8.71), indicating a bullish price trend. The MACD histogram is positive and the MACD signal is bullish, while the RSI sits at 51.9, suggesting no immediate overbought pressure. Support sits near CNY 10.24 and resistance near CNY 12.91. However, volume is on a decreasing trend, 30‑day volatility is high at 68 %, and the Fear‑Greed Index reads 91.46 (Extreme Greed), hinting at potential short‑term price fragility.
Fundamental outlook: Revenue grew 12.3 % to CNY 18.26 bn, but margins remain thin (gross 15.3 %, operating 7.9 %). The forward EPS of 0.48 points to earnings acceleration, yet the trailing P/E of 45.7 is well above the industry average of 38.1, and the DCF‑derived fair value of CNY 4.67 is far below the current price. Analysts target a mean price of CNY 15.48, implying ~30 % upside. Dividend yield is modest at 0.74 % with a 40 % payout, and the company holds more cash (CNY 4.13 bn) than debt (CNY 3.84 bn), supporting dividend sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above key moving averages and bullish MACD
  • High volatility and decreasing volume
  • Current valuation above DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 12.3 % and improving forward EPS
  • Target price suggests ~30 % upside
  • Strong cash position relative to debt supporting operations

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • DCF fair value far below market price indicating overvaluation
  • Thin profit margins and high P/E relative to peers
  • Sustainable dividend but limited yield

Key Metrics & Analysis

Financial Health

Revenue Growth12.30%
Profit Margin6.45%
P/E Ratio45.7
ROE7.92%
ROA3.09%
Debt/Equity21.88
P/B Ratio3.2
Op. Cash FlowCN¥3.1B
Free Cash FlowCN¥945.6M
Industry P/E38.1

Technical Analysis

TrendBullish
RSI51.9
SupportCN¥10.24
ResistanceCN¥12.91
MA 20CN¥11.71
MA 50CN¥11.68
MA 200CN¥8.71
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair ValueCN¥4.67
Target PriceCN¥15.48
Upside/Downside30.30%
GradeOvervalued
TypeBlend
Dividend Yield0.74%

Risk Assessment

Beta0.55
Volatility68.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.